Medicus Pharma (MDCXW) Liabilities and Shareholders Equity (2023 - 2025)

Medicus Pharma has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $10.1 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 78.18% year-over-year to $10.1 million; the trailing twelve-month figure through Dec 2025 stood at $37.6 million (up 566.41% YoY), and the FY2025 full-year result was $10.1 million, up 78.18% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $10.1 million, up from $10.0 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $11.9 million in Q2 2025, with the low at $1.9 million in Q4 2023.
• Historically, Liabilities and Shareholders Equity has averaged $7.5 million across 3 years, with a median of $7.8 million in 2025.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity surged 198.29% — and 2025, when it soared 78.18%.
• Medicus Pharma's Liabilities and Shareholders Equity stood at $1.9 million in 2023, then surged by 198.29% to $5.6 million in 2024, then surged by 78.18% to $10.1 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $10.1 million (Q4 2025), $10.0 million (Q3 2025), and $11.9 million (Q2 2025), per Business Quant data.